Carboplatin and paclitaxel for previously treated patients with non- small-cell lung cancer

Cancer Investigation

Volumn 16, Issue 6, 1998, Pages 381-384

  Roa, Veronica ^a   Conner, Anita ^a   Mitchell, R Brian ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0031880838     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809115777     Document Type: Article

References (19)

1. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1996. CA 65:5-27, 1996.
2. Souquet PJ, Chauvin F, Boissel JP, et al: Polychemotherapy in advanced non small cell lung cancer: A meta-analysis. Lancet 342:19-21, 1993.
3. Grilli R, Oxman AD, Julian JA: Chemotherapy for advanced non-small-cell lung cancer: How much benefit is enough? J Clin Oncol 11:1866-1872, 1993.
4. Sorensen JB, Clerici M, Hansen HH: Single-agent chemotherapy for advanced adenocarcinoma of the lung. Cancer Chemother Pharmacol 21:89-102, 1988.
5. Bonomi PD, Finkelstein DM, Ruckdeschel JC, et al: Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: A study of the Eastern Cooperative Oncology Group. J Clin Oncol 7:1602-1613, 1989.
6. Klastersky J, Sculier JP, Lacroix H, et al: A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer protocol 07861. J Clin Oncol 8:1556-1562, 1990.
7. Langer CJ, Leighton JC, Comis RL, et al: Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis. J Clin Oncol 13:1860-1870, 1995.
8. Evans WK, Steward DJ, Tomiak E, et al: Carboplatin and paclitaxel by one hour infusion for advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 14:374, 1995.
9. Paul D, Devore RD, Hande K, et al: Phase II trial of carboplatin + paclitaxel in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 14:361, 1995.
10. Rowinsky EK, Sartorious SE, Bowling MK, et al: Paclitaxel on a 3-hour schedule and carboplatin in non-small-cell lung cancer: Use of maximally tolerated and clinically relevant single agent doses in combination is feasible. Proc Am Soc Clin Oncol 14:354, 1995.
11. Vyberg M, Horn T, Francis D, et al: Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours. Acta Histochem 38(Suppl):179-181, 1990.
12. Mitchell RB, Goss B, Guarino M, et al: Phase II trial of bisnafide in advanced non-small-cell lung cancer. Proc Am Soc Clin Oncol 15:1230, 1996.
13. Chang AY, Kim K, Blick J, et al: Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group results. J Natl Cancer Inst 85:388-393, 1993.
14. Hainsworth JD, Thompson ES, Spigel SC, et al: Paclitaxel by 1-hour infusion in the treatment of stage IV or relapsed non-small-cell lung cancer. Proc Am Soc Clin Oncol 14:364, 1995.
15. Ruckdeschel J, Wagner H, Williams C, et al: Second line chemotherapy for resistant, metastatic, non-small-cell lung cancer: The role of Taxol. Proc Am Soc Clin Oncol 13:357, 1994.
16. Murphy WK, Winn RJ, Huber M, et al: Phase D study of Taxol in patients with non-small-cell lung cancer who have failed platinum containing chemotherapy. Proc Am Soc Clin Oncol 13:363, 1994.
17. Haas CD, Gallardo RL, Moore B, et al: Effective salvage chemotherapy for relapsed or refractory non-small-cell lung cancer with mitomycin-C + paclitaxel + metronidazole. Proc Am Soc Clin Oncol 15:391, 1996.
18. Roa V, Conner A, Mitchell RB: Carboplatin and paclitaxel for chemotherapy-naive patients with advanced non-small-cell lung cancer. Proc Am Soc Clin Oncol 15:404, 1996.
19. Calvert AH, Newell DR, Gumbrell LA, et al: Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 7:1748-1756, 1989.